SRX(SH:605168)2023-04-13 16:00Financial Performance - Total operating revenue for Q1 2023 reached ¥930,859,822.98, an increase of 4.4% compared to ¥894,769,497.38 in Q1 2022[10] - The company reported a net profit of ¥69,427,472.95 in Q1 2023, a significant recovery from a loss of ¥7,251,576.92 in the same period last year[10] - The net profit attributable to shareholders increased by 134.71%, primarily due to the growth in main business profits and investment returns from Juzhi Biotechnology[23] - The total profit for the period was ¥162,170,799.20, compared to ¥67,093,794.62 in the same period last year[47] - The comprehensive income total for the period was ¥142,696,812.64, a substantial increase from ¥60,138,997.81 year-over-year[47] Costs and Expenses - Total operating costs for Q1 2023 were ¥838,821,563.45, slightly up from ¥833,298,828.36 in Q1 2022[10] - Research and development expenses increased to ¥11,433,716.28 in Q1 2023, compared to ¥8,876,233.67 in Q1 2022, reflecting a growth of 28.3%[10] - Total cash payments for goods and services amounted to RMB 1,581,387,894.96 in Q1 2023, compared to RMB 798,500,994.55 in Q1 2022, reflecting a rise of approximately 98%[59] - Cash paid to employees increased to RMB 96,705,352.65 in Q1 2023 from RMB 60,210,052.78 in Q1 2022, marking an increase of around 60%[59] Cash Flow and Liquidity - Cash and cash equivalents decreased to ¥296,978,911.96 as of March 31, 2023, down from ¥558,958,299.50 at the end of 2022, representing a decline of 46.9%[6] - The net cash flow from operating activities was -489,018,289.90 RMB, compared to -349,933,347.59 RMB in the previous period[14] - The net cash flow from investment activities was -6,203,711.10 RMB, compared to -1,648,438.00 RMB in the previous period[14] - The net cash flow from financing activities was 240,414,462.14 RMB, compared to 172,740,367.59 RMB in the previous period[14] - Cash inflows from operating activities totaled RMB 1,267,978,803.12 in Q1 2023, up from RMB 602,821,173.10 in Q1 2022, representing a growth of approximately 110%[59] - Cash received from sales of goods and services was RMB 1,255,596,624.24 in Q1 2023, compared to RMB 584,759,952.12 in Q1 2022, indicating a year-over-year increase of about 114%[59] Assets and Liabilities - Total assets as of March 31, 2023, were ¥4,709,129,626.02, down from ¥5,307,487,463.86 at the end of 2022, indicating a decrease of 11.2%[8] - Total liabilities decreased to ¥1,968,044,054.82 from ¥2,710,143,163.61, a reduction of 27.3%[8] - The company’s equity attributable to shareholders increased to ¥2,719,799,312.65 from ¥2,577,599,922.50, reflecting a growth of 5.5%[8] Shareholder Information - The company had a total of 9,376 shareholders at the end of the reporting period[25] - The diluted earnings per share for the current period was 1.39 RMB, compared to 61.63 RMB in the previous period[21] - The basic earnings per share for the period was ¥1.39, reflecting a growth of 61.63% compared to the previous year[33] - The diluted earnings per share remained at ¥1.39, consistent with the basic earnings per share[48] Future Outlook and Strategy - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[12] - The company is focused on enhancing its core business operations to drive profitability[52] - The company has not provided any specific guidance for future performance in the conference call[54] Miscellaneous - The company recognized government subsidies amounting to ¥312,990.28, which are closely related to its normal business operations[35] - The report is based on unaudited financial statements for Q1 2023[56] - There were no audit opinion types applicable for the reporting period[53] - The company successfully executed advertising campaigns for major clients, contributing to stable profit growth[41]